Yearly Archives: 2020
Impactful Innovation Exchange: Calling all Solutions!
How can we advance the utilization of innovations in healthcare? By lending them extra visibility to key stakeholders! Join the Impactful Innovation Exchange, a free comprehensive platform that will showcase solutions from various organizations, created by Cambia Grove, with supporting organizations including BioUtah. Learn more and submit yours for FREE today: https://bit.ly/CGInnovationSubmission
bioMérieux receives Emergency Use Authorization for BIOFIRE® COVID-19 test
Marcy l’Étoile, France – March 24, 2020 – bioMérieux, a world leader in the field of in vitro diagnostics, today announced that its subsidiary, BioFire Defense, has received Emergency Use Authorization by the U.S. Food and Drug Administration of its BIOFIRE® COVID-19 test for use in CLIA moderate and high complexity clinical laboratories to detect SARS-CoV-2. The BIOFIRE® COVID-19 test detects […]
FDA Requires Review of COVID-19 Antibody Tests
To ensure the accuracy of COVID-19 antibody tests and guard against fraudulent testing claims, the FDA recently announced that it would update its March 16, 2020 guidance and start requiring serology test developers to obtain an Emergency Use Authorization (EUA). The agency has also outlined test performance expectations. Manufacturers that have already commercialized product based […]
Senate Democrats Announce Legislation to Federalize Medical Supply Chain
Senate Democrats, led by U.S. Senators Tammy Baldwin (D-WI) and Chris Murphy (D-CT), have announced legislation, The Medical Supply, Transparency and Delivery Act that lays out a framework for federalizing the response to COVID-19, including oversight and transparency related to the supply chain for critical medical supplies and equipment. The bill would require the president to utilize all available authorities under the […]
GAO Report Calls for Federal Action to Better Respond to the Impact of Antibiotic Resistance
The General Accounting Office (GAO) has released a report titled, “Antibiotic Resistance: Additional Federal Actions Needed to Better Determine Magnitude and Reduce Impact”. The report was conducted at the request of of the Senate Health, Education, Labor, and Pensions and House Energy and Commerce Committees. GAO was asked to review federal efforts related to (1) […]
AdvaMed Requests Tariff Exclusions for COVID-19 Related Medical Technology Products
Last week, AdvaMed sent a letter to the Office of the United States Trade Representative (USTR), urging that additional tariff exclusions be granted for medical devices, components and supplies coming from China needed in the fight against the COVID-19 pandemic. In the letter to USTR, AdvaMed requested tariff exclusions for more than 80 medical product […]
DeGette, Upton Outline Proposed “Cures 2.0”
U.S. Represetatives. Diana DeGette (D-CO) and Fred Upton (R-MI) have announced the concept paper for their bipartisan “Cures 2.0.” The concept paper outlines six key areas of focus for Cures 2.0, which seeks to modernize the delivery of healthcare in the wake of the COVID-19 pandemic. The six areas of focus are: Public Health Caregiver […]
Where to Find Economic Resources – PPP Update
Economic Resources: To help Utah companies identify resources to respond to the economic impact of COVID-19, the Utah Economic Response Task Force has created a tool that will help you determine the optimal federal, state, and local resources for your business. Economic Resource FinderFor information on federal resources click here. Utah PPP Update: The second […]
G2G – One Stop Shopping for Government Grants/Non-Dilutive Funding
Government to Growth (G2G) is led by Liz Powell, Esq., MPH, and includes a team of government affairs professionals who help startups, businesses and non-profits effectively navigate non-dilutive federal funding opportunities. With a specialty focus on life sciences, G2G tracks grants on a daily basis and produces a monthly GBG Report listing all bioscience funding […]
IDbyDNA Participates in NIH National COVID-19 Genomics Consortium
The CDC is leading the national SARS-CoV-2 Sequencing for Public Health Emergency Response, Epidemiology and Surveillance initiative (SPHERES) to coordinate SARS-CoV-2 sequencing across the U.S. Utah’s own IDbyDNA will be participating in the effort along with clinical and public health laboratories, academic institutions, and other private sector companies. The SPHERES consortium aims to generate information […]
Silver lining: opportunities can arise from the corona crisis
Author: Anja Petschauer Co-authors: Anna Derschang, Melitta Gilllespie gwSaar has been a member of BioUtah and a trusted partner of the State of Utah for many years. As a German investment promotion agency, we can observe the economic trends developing in our crisis-stricken global economy first-hand. We are honored that BioUtah has asked us to provide […]
